Hi Super!!!
That's a Super find you have there! You say "Wishful thinking perhaps?" - but I think it's an extremely interesting article indeed. Thanks very much indeed for ferreting this out and posting it.
I thought the Adaptimmune partnership was significant when that was announced. However although Hoos has made a few statements since then about GSK returning to Oncology in a big way I hadn't seen further positive signals.
It's never been a sure thing that GSK would be the one to do a deal with IMU, and I really do think there is serious competition, but GSK must be considered one of the leading contenders.
It sounds as though GSK is getting ready for some major moves so I wouldn't want to be sitting on the sidelines with IMU waiting to buy in at a lower price. Even if GSK doesn't seek a deal with IMU at this point, it's clear that the whole Oncological Immunotherapy field is set to boom.
2018 sure looks like being a fascinating year....
Cheers
Dave
Hi Super!!! That's a Super find you have there! You say "Wishful...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $404.2M | |||
| Open | High | Low | Value | Volume |
| 5.6¢ | 5.7¢ | 5.5¢ | $379.9K | 6.840M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 1581916 | 5.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.6¢ | 680013 | 6 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |